Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of AHB-137 in Healthy Participants and HBeAg-negative Chronic Hepatitis B (CHB) Patients [Phase 1, Phase 2]

View source ↗

Summary

A research update describing a Phase 1/2 clinical trial to evaluate the safety and efficacy of AHB-137 in healthy participants and patients with chronic hepatit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• AHB-137

Snippet

Sponsor: Ausper Biopharma Co., Ltd. | Conditions: Hepatitis B, Chronic | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING